Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs
One approach to protect new-borns against respiratory syncytial virus (RSV) is to vaccinate pregnant women in the last trimester of pregnancy. The boosting of circulating antibodies which can be transferred to the foetus would offer immune protection against the virus and ultimately the disease. Sin...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c8d05755ffa4400bec63cc9820e65cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1c8d05755ffa4400bec63cc9820e65cd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1c8d05755ffa4400bec63cc9820e65cd2021-11-25T18:38:18ZTransplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs10.3390/pathogens101114412076-0817https://doaj.org/article/1c8d05755ffa4400bec63cc9820e65cd2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-0817/10/11/1441https://doaj.org/toc/2076-0817One approach to protect new-borns against respiratory syncytial virus (RSV) is to vaccinate pregnant women in the last trimester of pregnancy. The boosting of circulating antibodies which can be transferred to the foetus would offer immune protection against the virus and ultimately the disease. Since non-human primates (NHPs) have similar reproductive anatomy, physiology, and antibody architecture and kinetics to humans, we utilized this preclinical species to evaluate maternal immunization (MI) using an RSV F subunit vaccine. Three species of NHPs known for their ability to be infected with human RSV in experimental challenge studies were tested for RSV-specific antibodies. African green monkeys had the highest overall antibody levels of the old-world monkeys evaluated and they gave birth to offspring with anti-RSV titers that were proportional to their mother. These higher overall antibody levels are associated with greater durability found in their offspring. Immunization of RSV seropositive AGMs during late pregnancy boosts RSV titers, which consequentially results in significantly higher titers in the vaccinated new-borns compared to the new-borns of unvaccinated mothers. These findings, accomplished in small treatment group sizes, demonstrate a model that provides an efficient, resource sparing and translatable preclinical in vivo system for evaluating vaccine candidates for maternal immunization.Michael P. CitronJessica McAnultyCheryl CallahanWalter KnappJane FontenotPablo MoralesJessica A. FlynnCameron M. DouglasAmy S. EspesethMDPI AGarticlematernal antibodyanimal modelrespiratory syncytial virus (RSV)non-human primatematernal immunizationMedicineRENPathogens, Vol 10, Iss 1441, p 1441 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
maternal antibody animal model respiratory syncytial virus (RSV) non-human primate maternal immunization Medicine R |
spellingShingle |
maternal antibody animal model respiratory syncytial virus (RSV) non-human primate maternal immunization Medicine R Michael P. Citron Jessica McAnulty Cheryl Callahan Walter Knapp Jane Fontenot Pablo Morales Jessica A. Flynn Cameron M. Douglas Amy S. Espeseth Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
description |
One approach to protect new-borns against respiratory syncytial virus (RSV) is to vaccinate pregnant women in the last trimester of pregnancy. The boosting of circulating antibodies which can be transferred to the foetus would offer immune protection against the virus and ultimately the disease. Since non-human primates (NHPs) have similar reproductive anatomy, physiology, and antibody architecture and kinetics to humans, we utilized this preclinical species to evaluate maternal immunization (MI) using an RSV F subunit vaccine. Three species of NHPs known for their ability to be infected with human RSV in experimental challenge studies were tested for RSV-specific antibodies. African green monkeys had the highest overall antibody levels of the old-world monkeys evaluated and they gave birth to offspring with anti-RSV titers that were proportional to their mother. These higher overall antibody levels are associated with greater durability found in their offspring. Immunization of RSV seropositive AGMs during late pregnancy boosts RSV titers, which consequentially results in significantly higher titers in the vaccinated new-borns compared to the new-borns of unvaccinated mothers. These findings, accomplished in small treatment group sizes, demonstrate a model that provides an efficient, resource sparing and translatable preclinical in vivo system for evaluating vaccine candidates for maternal immunization. |
format |
article |
author |
Michael P. Citron Jessica McAnulty Cheryl Callahan Walter Knapp Jane Fontenot Pablo Morales Jessica A. Flynn Cameron M. Douglas Amy S. Espeseth |
author_facet |
Michael P. Citron Jessica McAnulty Cheryl Callahan Walter Knapp Jane Fontenot Pablo Morales Jessica A. Flynn Cameron M. Douglas Amy S. Espeseth |
author_sort |
Michael P. Citron |
title |
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
title_short |
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
title_full |
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
title_fullStr |
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
title_full_unstemmed |
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs |
title_sort |
transplacental antibody transfer of respiratory syncytial virus specific igg in non-human primate mother-infant pairs |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/1c8d05755ffa4400bec63cc9820e65cd |
work_keys_str_mv |
AT michaelpcitron transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT jessicamcanulty transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT cherylcallahan transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT walterknapp transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT janefontenot transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT pablomorales transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT jessicaaflynn transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT cameronmdouglas transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs AT amysespeseth transplacentalantibodytransferofrespiratorysyncytialvirusspecificigginnonhumanprimatemotherinfantpairs |
_version_ |
1718410878601134080 |